Clinical Trial Update: Switch and Maintenance Study of Intravenous Injections of R744 to Hemodialysis Patients (Phase Ⅲ Study) [Phase 3]

View source ↗

Summary

Chugai Pharmaceutical reports completion of a Phase 3 switch-and-maintenance trial evaluating intravenous R744 in hemodialysis patients. The study status is COM…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease

Drugs mentioned

• R744

Snippet

Sponsor: Chugai Pharmaceutical | Conditions: Hemodialysis Patients | Phase 3 | Status: COMPLETED